Drugs / 2,3-dimercaptopropane-1-sulfonate
2,3-dimercaptopropane-1-sulfonate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01059474 | Apr → Dec 2010 | poisoning | Banner Health | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 2,3-dimercaptopropane-1-sulfonate | “2,3-dimercaptopropane-1-sulfonate (DMPS) is a chelating agent that has been used for years in Europe for treatment of poisoning by metals such as mercury, arsenic, and lead.” NCT01059474 ↗ |
| Known as | Dimaval | “DMPS is not FDA approved, but is approved in Europe and is available in Germany without a prescription, as Dimaval.” NCT01059474 ↗ |
| Known as | DMPS | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01059474 ↗ |